Search research articles
Contact Us
Filters
Showing results (171-180 of 207) with videos related to
Page
of 21
Sort By:
Health Physics
|
February 25, 2014
Radiation safety considerations for the use of ²²³RaCl₂ DE in men with castration-resistant prostate cancer
Lawrence T Dauer, Matthew J Williamson, John Humm, et al.
Annals of Surgery
|
May 16, 2013
Burn injury enhances bone formation in heterotopic ossification model
Jonathan R Peterson, Sara De La Rosa, Hongli Sun, et al.
Pharmaceutical Research
|
March 20, 2014
Biorelevant in vitro performance testing of orally administered dosage forms-workshop report
Christos Reppas, Horst-Dieter Friedel, Amy R Barker, et al.
AAPS Pharmscitech
|
June 21, 2011
FIP/AAPS joint workshop report: dissolution/in vitro release testing of novel/special dosage forms
Cynthia K Brown, Horst Dieter Friedel, Amy R Barker, et al.
Blood Advances
|
June 17, 2024
Safety and feasibility of third-party cytotoxic T lymphocytes for high-risk patients with COVID-19
Dolores Grosso, John L Wagner, Allyson O'Connor, et al.
Journal of Pharmaceutical Sciences
|
August 28, 2018
FIP Guidelines for Dissolution Testing of Solid Oral Products
Horst Dieter Friedel, Cynthia K Brown, Amy R Barker, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 30, 2013
Phase II study of Lutetium-177-labeled anti-prostate-specific membrane antigen monoclonal antibody J591 for metastatic castration-resistant prostate cancer
Scott T Tagawa, Matthew I Milowsky, Michael Morris, et al.
Pediatric Research
|
July 24, 2023
Outcomes by disease onset, sex, and intervention in neonates with SIP and surgical NEC
Parvesh Mohan Garg, Katheryn Lett, Md Abu Yusuf Ansari, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
March 6, 2004
Tumor localization of 16beta-18F-fluoro-5alpha-dihydrotestosterone versus 18F-FDG in patients with progressive, metastatic prostate cancer
Steven M Larson, Michael Morris, Ilonka Gunther, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 5, 2014
Randomized controlled trial of early zoledronic acid in men with castration-sensitive prostate cancer and bone metastases: results of CALGB 90202 (alliance)
Matthew R Smith, Susan Halabi, Charles J Ryan, et al.
Page
of 21
Search research articles
Search
Showing results (171-180 of 207) with videos related to
Sort By:
Page
of 21
Health Physics
|
February 25, 2014
Radiation safety considerations for the use of ²²³RaCl₂ DE in men with castration-resistant prostate cancer
Lawrence T Dauer, Matthew J Williamson, John Humm, et al.
Annals of Surgery
|
May 16, 2013
Burn injury enhances bone formation in heterotopic ossification model
Jonathan R Peterson, Sara De La Rosa, Hongli Sun, et al.
Pharmaceutical Research
|
March 20, 2014
Biorelevant in vitro performance testing of orally administered dosage forms-workshop report
Christos Reppas, Horst-Dieter Friedel, Amy R Barker, et al.
AAPS Pharmscitech
|
June 21, 2011
FIP/AAPS joint workshop report: dissolution/in vitro release testing of novel/special dosage forms
Cynthia K Brown, Horst Dieter Friedel, Amy R Barker, et al.
Blood Advances
|
June 17, 2024
Safety and feasibility of third-party cytotoxic T lymphocytes for high-risk patients with COVID-19
Dolores Grosso, John L Wagner, Allyson O'Connor, et al.
Journal of Pharmaceutical Sciences
|
August 28, 2018
FIP Guidelines for Dissolution Testing of Solid Oral Products
Horst Dieter Friedel, Cynthia K Brown, Amy R Barker, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 30, 2013
Phase II study of Lutetium-177-labeled anti-prostate-specific membrane antigen monoclonal antibody J591 for metastatic castration-resistant prostate cancer
Scott T Tagawa, Matthew I Milowsky, Michael Morris, et al.
Pediatric Research
|
July 24, 2023
Outcomes by disease onset, sex, and intervention in neonates with SIP and surgical NEC
Parvesh Mohan Garg, Katheryn Lett, Md Abu Yusuf Ansari, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
March 6, 2004
Tumor localization of 16beta-18F-fluoro-5alpha-dihydrotestosterone versus 18F-FDG in patients with progressive, metastatic prostate cancer
Steven M Larson, Michael Morris, Ilonka Gunther, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 5, 2014
Randomized controlled trial of early zoledronic acid in men with castration-sensitive prostate cancer and bone metastases: results of CALGB 90202 (alliance)
Matthew R Smith, Susan Halabi, Charles J Ryan, et al.
Page
of 21